Goldman Sachs’s Castle Biosciences CSTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.58M | Buy |
273,443
+98,118
| +56% | +$2M | ﹤0.01% | 2721 |
|
|
2025
Q1 | $3.51M | Sell |
175,325
-257,425
| -59% | -$5.15M | ﹤0.01% | 2984 |
|
|
2024
Q4 | $11.5M | Buy |
432,750
+189,950
| +78% | +$5.06M | ﹤0.01% | 2210 |
|
|
2024
Q3 | $6.92M | Buy |
242,800
+25,663
| +12% | +$732K | ﹤0.01% | 2536 |
|
|
2024
Q2 | $4.73M | Buy |
217,137
+92,465
| +74% | +$2.01M | ﹤0.01% | 2648 |
|
|
2024
Q1 | $2.76M | Buy |
124,672
+44,283
| +55% | +$981K | ﹤0.01% | 2989 |
|
|
2023
Q4 | $1.73M | Sell |
80,389
-71,362
| -47% | -$1.54M | ﹤0.01% | 3300 |
|
|
2023
Q3 | $2.56M | Buy |
151,751
+70,030
| +86% | +$1.18M | ﹤0.01% | 2940 |
|
|
2023
Q2 | $1.12M | Sell |
81,721
-56,193
| -41% | -$771K | ﹤0.01% | 3550 |
|
|
2023
Q1 | $3.13M | Sell |
137,914
-108,942
| -44% | -$2.48M | ﹤0.01% | 2895 |
|
|
2022
Q4 | $5.81M | Buy |
246,856
+64,184
| +35% | +$1.51M | ﹤0.01% | 2510 |
|
|
2022
Q3 | $4.76M | Buy |
182,672
+62,987
| +53% | +$1.64M | ﹤0.01% | 2672 |
|
|
2022
Q2 | $2.63M | Buy |
119,685
+56,463
| +89% | +$1.24M | ﹤0.01% | 3229 |
|
|
2022
Q1 | $2.84M | Sell |
63,222
-8,186
| -11% | -$367K | ﹤0.01% | 3292 |
|
|
2021
Q4 | $3.06M | Sell |
71,408
-156,106
| -69% | -$6.69M | ﹤0.01% | 3173 |
|
|
2021
Q3 | $15.1M | Sell |
227,514
-107,101
| -32% | -$7.12M | ﹤0.01% | 1946 |
|
|
2021
Q2 | $24.5M | Sell |
334,615
-69,519
| -17% | -$5.1M | 0.01% | 1582 |
|
|
2021
Q1 | $27.7M | Buy |
404,134
+41,869
| +12% | +$2.87M | 0.01% | 1444 |
|
|
2020
Q4 | $24.3M | Sell |
362,265
-52,651
| -13% | -$3.54M | 0.01% | 1426 |
|
|
2020
Q3 | $21.3M | Buy |
414,916
+114,289
| +38% | +$5.88M | 0.01% | 1437 |
|
|
2020
Q2 | $11.3M | Sell |
300,627
-12,362
| -4% | -$466K | ﹤0.01% | 1864 |
|
|
2020
Q1 | $9.33M | Buy |
312,989
+8,800
| +3% | +$262K | ﹤0.01% | 1838 |
|
|
2019
Q4 | $10.5M | Buy |
304,189
+2,467
| +0.8% | +$84.8K | ﹤0.01% | 2017 |
|
|
2019
Q3 | $5.46M | Buy |
+301,722
| New | +$5.46M | ﹤0.01% | 2271 |
|